Neuropathy and Pain Solutions

What Neuropathy and Pain Solutions does

Neuropathy and Pain Solutions is a privately held, integrative medical clinic that operates three physical locations in South St. Louis County MO, Swansea IL, and Marion IL, serving adults suffering from chronic pain and neuropathy in the greater St. Louis metropolitan area and Southern Illinois. The clinic's core offering is a standardized 12-week treatment program built around Electric Cell Signaling Treatment (EST), an FDA-cleared, non-surgical, drug-free therapy that applies carefully controlled electrical signals to damaged nerves, combined with physical therapy, ergonomic tools, and stretches tailored to individual patients. It also offers ancillary services including trigger point injections, joint injections, hormone replacement therapy, migraine/Botox therapy, and weight loss management. The clinic reports that 87% of patients experience significant relief from neuropathy symptoms following EST.

The clinical team consists of six providers — nurse practitioners, physician assistants (including a dual-credentialed DC/PA-C with prior neurosurgery and Washington University research experience), and a registered nurse — collectively trained at institutions including Barnes-Jewish College, Saint Louis University, SIU School of Medicine, and Logan University. The company is privately owned with no disclosed venture capital or private equity backing, and appears to be physician/founder-led, with HIPAA-compliant operations and a designated privacy officer. Revenue is generated entirely through professional services fees billed to patients (via insurance or self-pay), with no public pricing disclosure and no digital product or wholesale distribution component.

Patient acquisition relies on a direct-to-consumer funnel: vanity phone numbers (LIFE suffix) at each location, online appointment booking through the company website, a content marketing blog covering neuropathy symptoms and wellness topics, and a Facebook community presence. The company cites a U.S. chronic pain population of approximately 56 million adults as its addressable market and positions itself around outcomes (pain relief, restored mobility, reduced reliance on medication) rather than transactional volume.

Name

Neuropathy and Pain Solutions

Legal name

Neuropathy and Pain Solutions

Website

https://neuropathyandpainsolutions.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Neuropathy and Pain Solutions is a privately held, integrative medical clinic operating three locations in Missouri and Illinois, treating adult chronic pain and neuropathy patients with an FDA-cleared, non-surgical Electric Cell Signaling Treatment program delivered by nurse practitioners and physician assistants.

Ownership category

akta.pro rank

Product category

Pain Management Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Pain Management Clinics (Interventional & Medical) (HLAFABAH)

akta.pro secondary industries

Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Chronic Pain Rehabilitation & Functional Restoration (HSADAIAJ)

Keywords

• Neuropathy treatment
• Chronic pain management
• Integrative medicine clinic
• Pain management services
• Nerve pain therapy

Headquarters

HQ city

St. Louis

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Treatment Services: Revenue generated from patient evaluations and treatment sessions including Electric Cell Signaling Treatment, trigger point injections, joint injections, hormone replacement therapy, and other pain management services. Treatment plans are individualized and typically span 12 weeks.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Neuropathy and Pain Solutions is an integrative medical clinic that delivers Electric Cell Signaling Treatment (EST), an FDA-cleared, non-surgical therapy using controlled electrical signals to soothe damaged nerves and relieve neuropathy and chronic pain symptoms. Treatment plans are individualized, typically spanning 12 weeks with 2 appointments per week (24 sessions of 30–40 minutes), and are supplemented by trigger point injections, joint injections, hormone replacement therapy, physical therapy, ergonomic tools, and stretches. The clinic operates three locations serving the St. Louis metro and Southern Illinois markets.

Product overview

Neuropathy and Pain Solutions offers a single unified treatment program centered on Electric Cell Signaling Treatment (EST), their FDA-cleared, non-surgical therapy for neuropathy and chronic pain conditions. The treatment applies carefully controlled electrical signals to affected regions to soothe damaged nerves. Their integrative approach combines EST with physical therapy, ergonomic tools, and stretches, all customized to individual patient needs. They treat conditions including neuropathy symptoms, back pain, diabetes, joint pain, chronic pain, neck pain, sciatica, shingles, and knee pain. The company reports that 87% of patients experience significant relief from symptoms.

Differentiator

Problem solved

Functional benefit

Products and services

• Electric Cell Signaling Treatment (EST)

Quantifiable outcome

• 87% of patients experience significant relief from neuropathy symptoms after EST treatment
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• SWORD Health: Digital MSK and chronic pain therapy provider pairing virtual physical therapy with at-home devices. Targets the same chronic pain patient demographics as NPS, but through employer/payer-sponsored digital programs.
• BioElectronics Corporation: Markets ActiPatch and RecoveryRx pulsed shortwave therapy devices for pain relief including neuropathic pain. Comparable technology basis (electromagnetic/electrical signaling) and same chronic pain patient positioning.
• Hinge Health: Digital chronic pain management platform combining exercise therapy, coaching, and sometimes wearable TENS. Comparable patient base of chronic musculoskeletal and neuropathic pain sufferers, delivered via a virtual-first model.
• NeuroMetrix: Maker of the Quell wearable neurostimulation device for chronic pain and neuropathy. Targets the same neuropathy patient base as NPS, but via a home-use device model rather than in-clinic treatment.

Broad incumbents

• Medtronic (Pain Therapies): Global medtech incumbent offering spinal cord and targeted drug delivery stimulation systems for chronic intractable pain. Competes indirectly by serving end-stage neuropathy patients who exhaust non-surgical options like EST.
• Abbott (Neuromodulation): Major medical device incumbent with a neuromodulation portfolio (Proclaim, Eterna) targeting chronic pain and neuropathic conditions. Represents a large institutional competitor addressing the same patient conditions via implanted devices.
• Nevro: Markets HF10 high-frequency spinal cord stimulation for chronic pain, including neuropathy indications. Operates in the broader chronic pain management space that competes for the same pool of patients NPS serves.
• SPR Therapeutics: Commercial-stage peripheral nerve stimulation company (SPRINT system) addressing chronic neuropathic pain. Comparable in treating damaged nerve pain, though it operates via implantable devices rather than non-surgical clinic visits.

Direct peers

• Capitol Pain Institute: Multi-site interventional pain management clinic group offering injections, nerve blocks, and neuromodulation for chronic pain and neuropathy. Closely comparable operating model: multi-location outpatient pain clinics with similar service mix.
• Calmare Therapeutics: Offers Calmare scrambler therapy, an FDA-cleared non-invasive electrical neuropathic pain treatment delivered in clinic settings. Highly comparable to NPS's EST in modality (controlled electrical signals to nerves) and patient positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/neuropathyandpainsolutions
• LinkedInlinkedin.com/company/neuropathy-and-pain-solutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuropathy and Pain Solutions